secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2022-11-04T23:59:59+00:00
Accession:  0000721371-22-000131
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q1 FY23 revenue up 13% to $49.6B; GAAP EPS $0.40, non-GAAP EPS $1.20; Medical segment posts loss
--------------------------------------------------------------------------------

- GAAP operating earnings $137M, including $154M goodwill impairment; GAAP diluted EPS $0.40, down 57% YoY.
- Non-GAAP operating earnings $423M (-20% YoY); non-GAAP diluted EPS $1.20 (-7% YoY).
- Pharmaceutical segment profit up 6% to $431M; Medical segment loss of $8M vs $123M profit prior year.
- Revised FY23 Medical segment profit outlook to flat to 20% decline; reaffirms non-GAAP EPS guidance $5.05-$5.40.
- Updated FY23 interest/other expense to $140M-$160M, non-GAAP tax rate 23%-24%, diluted shares ~262-264M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137122000131/0000721371-22-000131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137122000131/cah-20221104.htm
  HTML page:      https://secwatch.observer/filing/0000721371-22-000131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer